Back

The dimer interface of ERK1/2 provides a potential strategy for selective inhibition of pathological cardiac hypertrophy

30 April 2017 (14:15 - 14:30)
Organised by:
Congress Presentation Part of: Young Investigator Award: Basic Science and Translational Science Cell Signalling HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Ms Angela Tomasovic

Institute of Pharmacology and Toxicology, Wuerzburg (Germany)

5 More presentations in this session

Presentation thumbnail
Hypercontractile heart and delayed cardiomyopathy in mice with cardiac-specific ablation of the RIalpha subunit of cAMP-dependent protein kinase
Mr I. Bedioune (Chatenay-Malabry, FR)
Abstract
Presentation thumbnail
Rac1 regulates mineralocorticoid receptor mediated pro-fibrotic remodeling through 11beta hydroxysteroid dehydrogenase type 2
Doctor D. Lavall (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
Supercomplex-dependent improvements in mitochondrial function with the mitochondria-targeting peptide elamipretide
Mr J. Perry (Blacksburg, US)
Abstract Slides Video
Presentation thumbnail
Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH
Mr A. van der Pol (Eindhoven, NL)
Abstract
Presentation thumbnail
Investigation of myocardial sarcomerdynamics and myocardial sarcomeric protein alterations in a rodent model of physiological hypertrophy
Doctor A. Olah (Budapest, HU)
Abstract

Access the full session

Session thumbnail
Young Investigator Award: Basic Science and Translational Science

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

30 April 2017 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources